GeneVentiv Therapeutics Inc.
GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease.
1
Funding Rounds
$2.0m
Money raised
Overview
GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ch****** Li | - | - | - |
Funding series
Funding Series Analysis
The company GeneVentiv Therapeutics Inc. has raised a total of $2m in funding over 1 rounds.
Key Insights:
- GeneVentiv Therapeutics, Inc. Funding Round, August 2022: $2m
GeneVentiv Therapeutics, Inc. Funding Round, August 2022
$2m
Industries
GeneVentiv Therapeutics Inc. is active in the following industries: